AstraZeneca Seeks Quick Win In Drug Price Negotiation Fight
Pharmaceutical company AstraZeneca asked a Delaware federal judge Tuesday to rule that the Inflation Reduction Act's provision allowing the government to negotiate drug prices oversteps statutory authority and is ultimately unlawful....To view the full article, register now.
Already a subscriber? Click here to view full article